샘플 요청 목록

 카트 문의
시장보고서
상품코드
2040798

미국의 Cath Labs 시장 규모, 점유율 및 동향 분석 보고서 : 컴포넌트별, 시설 유형별, 주요 기업 및 경쟁 분석, 부문 예측(2026-2033년)

U.S. Cath Labs Market Size, Share & Trends Analysis Report By Component (Services, Equipment, Medical Devices), By Facility Type (Independent, Hospital-based), Key Companies And Competitive Analysis And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: 구분자 Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.
US $ 3,950 금액 안내 화살표 ￦ 6,113,000
Printable PDF & Excel (5-User License) help
보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.
US $ 4,950 금액 안내 화살표 ￦ 7,661,000
Printable PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 6,950 금액 안내 화살표 ￦ 10,757,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

미국의 Cath Labs 시장 요약

미국의 Cath Labs 시장 규모는 2025년에 168억 달러로 추계되며, 2033년에는 177억 달러에 달할 것으로 예측되고 있으며, 2026-2033년에 CAGR 5.5%로 성장할 전망입니다.

심혈관 질환의 높은 유병률과 진단 기술의 발전으로 시장은 크게 성장할 것으로 예상됩니다.

또한 국민들의 의료비 지출 증가와 심장 건강에 대한 인식 개선을 위한 연방 정부의 노력은 시장 성장 기회를 확대시키고 있습니다. 미국에서는 20세 이상 인구 중 약 2,010만 명이 관상동맥질환을 앓고 있습니다. 또한 매년 80만 5,000명의 미국인이 심근경색을 앓고 있습니다. 미국 질병예방통제센터(CDC)에 따르면 웨스트버지니아주는 미국에서 심장병 유병률이 가장 높은 주이며, 연령 조정된 유병률은 6.3%에 달합니다.

본 섹션에서는 심장 질환의 증가, 신기술 도입 확대, 임상 품질에 대한 중요성 증가 등 미국 카테터 검사실(Cath Lab) 산업의 성장을 이끄는 주요 요인들을 다루고 있습니다.

자주 묻는 질문

  • 미국의 Cath Labs 시장 규모는 어떻게 예측되나요?
  • 미국에서 심혈관 질환의 유병률은 어떻게 되나요?
  • 미국에서 심장병 유병률이 가장 높은 주는 어디인가요?
  • 미국 Cath Lab 산업의 성장 요인은 무엇인가요?

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 : 변수, 동향, 범위

제4장 컴포넌트별 비즈니스 분석

제5장 시설 유형별 비즈니스 분석

제6장 제조 기업의 상황 개요

제7장 서비스 프로바이더 기업의 현황

KSA

U.S. Cath Labs Market Summary

The U.S. cath labs market size was estimated at USD 16.8 billion in 2025 and is projected to reach USD 17.7 billion in 2033, growingat a CAGR of 5.5% from 2026 to 2033. The market is expected to grow significantly owing to the high incidence of cardiovascular diseases and the technological advancements in diagnostic techniques.

In addition, the growing expenditure on healthcare by the citizens and the initiatives by the federal government to increase awareness regarding cardiac health are increasing the growth opportunities for the market. Approximately 20.1 million residents in the U.S. above 20 years of age have coronary artery disease. 805,000 Americans have a heart attack annually. West Virginia has the highest prevalence of heart disorders in the U.S., with an age-weighted prevalence of 6.3% as per the CDC.

The section highlights the key factors driving the growth of the U.S. cath labs industry, including rising heart diseases, increasing adoption of new technologies, and growing emphasis on clinical excellence, among others.

U.S. Cath Labs Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. cath labs market report based on component, and facility type.

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Services
    • Therapeutic
    • Angioplasty
    • Stent placement
    • Rotational atherectomy
    • Thrombectomy
    • Cardioversion
    • Transcatheter Aortic Valve Replacement (TAVR)
    • Others
    • Diagnostic
    • Angiography
    • Coronary intravascular ultrasound
    • Cardiac catheterization
    • ECG/EKG
    • Fractional Flow Reserve (FFR)
    • Others
  • Equipment
    • Imaging Equipment
    • Angiography machines
    • X-ray machines
    • IVUS
    • Monitors
    • Procedure Room Equipment
    • X-ray table
    • Heart monitoring equipment
    • Display screens
    • Control Room Equipment
    • Viewing monitor
    • Hemodynamic monitoring system
    • Other Equipment
    • Infusion pumps
    • Anesthetic and respiratory equipment
    • Crash cart
  • Medical Devices
    • Stents
    • Sheaths
    • Guidewires
    • Pacemakers
    • Defibrillator
    • CPR device
    • Others
  • Facility Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Independent Labs
  • Hospital-Based Labs

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
    • 1.4.5. Details of Primary Research
    • 1.4.6. Research Assumption
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. Objectives
    • 1.8.1. Objective - 1
    • 1.8.2. Objective - 2
    • 1.8.3. Objective - 3
  • 1.9. List of Secondary Sources
  • 1.10. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. U.S. Cath Labs Market
    • 2.1.1. Market Snapshot
    • 2.1.2. Segment Snapshot
      • 2.1.2.1. Component segment outlook
      • 2.1.2.2. Facility type segment outlook
    • 2.1.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Rising incidence of cardiovascular disease
      • 3.3.1.2. Low operational cost
      • 3.3.1.3. Technological advancement
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Lack of reimbursement for independent lab
      • 3.3.2.2. High maintenance cost for multispecialty labs
  • 3.4. Regulatory Framework
  • 3.5. Business Environment Analysis Tools
    • 3.5.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis

Chapter 4. Component Business Analysis

  • 4.1. U.S. Cath Labs Market: Component Movement Analysis
  • 4.2. U.S. Cath Labs Market: Component Segment Dashboard
  • 4.3. Component Movement & Market Share Analysis, 2025 & 2033
  • 4.4. U.S. Cath Labs Market Estimates & Forecast, by Component
  • 4.5. Services
    • 4.5.1. Services market, 2021 - 2033 (USD Million)
    • 4.5.2. Therapeutics
      • 4.5.2.1. Therapeutics market, 2021 - 2033 (USD Million)
      • 4.5.2.2. Angioplasty market, 2021 - 2033 (USD Million)
        • 4.5.2.2.1. Angioplasty market, 2021 - 2033 (USD Million)
      • 4.5.2.3. Stent placement market, 2021 - 2033 (USD Million)
        • 4.5.2.3.1. Stent placement market, 2021 - 2033 (USD Million)
      • 4.5.2.4. Rotational atherectomy market, 2021 - 2033 (USD Million)
        • 4.5.2.4.1. Rotational atherectomy market, 2021 - 2033 (USD Million)
      • 4.5.2.5. Thrombectomy market, 2021 - 2033 (USD Million)
        • 4.5.2.5.1. Thrombectomy market, 2021 - 2033 (USD Million)
      • 4.5.2.6. Cardioversion market, 2021 - 2033 (USD Million)
        • 4.5.2.6.1. Cardioversion market, 2021 - 2033 (USD Million)
      • 4.5.2.7. Transcatheter Aortic Valve Replacement (TAVR) market, 2021 - 2033 (USD Million)
        • 4.5.2.7.1. Transcatheter Aortic Valve Replacement (TAVR) market, 2021 - 2033 (USD Million)
      • 4.5.2.8. Others market, 2021 - 2033 (USD Million)
        • 4.5.2.8.1. Others market, 2021 - 2033 (USD Million)
    • 4.5.3. Diagnostic
      • 4.5.3.1. Diagnostic market, 2021 - 2033 (USD Million)
      • 4.5.3.2. Angiography market, 2021 - 2033 (USD Million)
        • 4.5.3.2.1. Angiography market, 2021 - 2033 (USD Million)
      • 4.5.3.3. Coronary intravascular ultrasound market, 2021 - 2033 (USD Million)
        • 4.5.3.3.1. Coronary intravascular ultrasound market, 2021 - 2033 (USD Million)
      • 4.5.3.4. Cardiac catheterization market, 2021 - 2033 (USD Million)
        • 4.5.3.4.1. Cardiac catheterization market, 2021 - 2033 (USD Million)
      • 4.5.3.5. ECG/EKG market, 2021 - 2033 (USD Million)
        • 4.5.3.5.1. ECG/EKG market, 2021 - 2033 (USD Million)
      • 4.5.3.6. Fractional Flow Reserve (FFR) market, 2021 - 2033 (USD Million)
        • 4.5.3.6.1. Fractional Flow Reserve (FFR) market, 2021 - 2033 (USD Million)
      • 4.5.3.7. Others market, 2021 - 2033 (USD Million)
        • 4.5.3.7.1. Others market, 2021 - 2033 (USD Million)
  • 4.6. Equipment
    • 4.6.1. Equipment market, 2021 - 2033 (USD Million)
    • 4.6.2. Imaging Equipment
      • 4.6.2.1. Imaging equipment market, 2021 - 2033 (USD Million)
      • 4.6.2.2. X-ray machines market, 2021 - 2033 (USD Million)
        • 4.6.2.2.1. X-ray machines market, 2021 - 2033 (USD Million)
      • 4.6.2.3. Angiography machines market, 2021 - 2033 (USD Million)
        • 4.6.2.3.1. Angiography machines market, 2021 - 2033 (USD Million)
      • 4.6.2.4. IVUS market, 2021 - 2033 (USD Million)
        • 4.6.2.4.1. IVUS market, 2021 - 2033 (USD Million)
    • 4.6.3. Monitors
        • 4.6.3.1.1. Monitors market, 2021 - 2033 (USD Million)
    • 4.6.4. Procedure room equipment
      • 4.6.4.1. Procedure room equipment market, 2021 - 2033 (USD Million)
      • 4.6.4.2. X-ray table market, 2021 - 2033 (USD Million)
        • 4.6.4.2.1. X-ray table market, 2021 - 2033 (USD Million)
      • 4.6.4.3. Heart monitoring equipment market, 2021 - 2033 (USD Million)
        • 4.6.4.3.1. Heart monitoring equipment market, 2021 - 2033 (USD Million)
      • 4.6.4.4. Display screens market, 2021 - 2033 (USD Million)
        • 4.6.4.4.1. Display screens market, 2021 - 2033 (USD Million)
    • 4.6.5. Control room equipment
      • 4.6.5.1. Control room equipment market, 2021 - 2033 (USD Million)
      • 4.6.5.2. Viewing monitor market, 2021 - 2033 (USD Million)
        • 4.6.5.2.1. Viewing monitor market, 2021 - 2033 (USD Million)
      • 4.6.5.3. Hemodynamic monitoring system market, 2021 - 2033 (USD Million)
        • 4.6.5.3.1. Hemodynamic monitoring system market, 2021 - 2033 (USD Million)
    • 4.6.6. Other equipment
      • 4.6.6.1. Other equipment market, 2021 - 2033 (USD Million)
      • 4.6.6.2. Infusion pumps market, 2021 - 2033 (USD Million)
        • 4.6.6.2.1. Infusion pumps market, 2021 - 2033 (USD Million)
      • 4.6.6.3. Anesthetic and respiratory equipment market, 2021 - 2033 (USD Million)
        • 4.6.6.3.1. Anesthetic and respiratory equipment market, 2021 - 2033 (USD Million)
      • 4.6.6.4. Crash cart market, 2021 - 2033 (USD Million)
        • 4.6.6.4.1. Crash cart market, 2021 - 2033 (USD Million)
  • 4.7. Medical Devices
    • 4.7.1. Medical devices market, 2021 - 2033 (USD Million)
    • 4.7.2. Stents
      • 4.7.2.1. Stents market, 2021 - 2033 (USD Million)
    • 4.7.3. Sheaths
      • 4.7.3.1. Sheaths market, 2021 - 2033 (USD Million)
    • 4.7.4. Guidewires
      • 4.7.4.1. Guidewires market, 2021 - 2033 (USD Million)
    • 4.7.5. Pacemakers
      • 4.7.5.1. Pacemakers market, 2021 - 2033 (USD Million)
    • 4.7.6. Defibrillator
      • 4.7.6.1. Defibrillator market, 2021 - 2033 (USD Million)
    • 4.7.7. CPR device
      • 4.7.7.1. CPR device market, 2021 - 2033 (USD Million)
    • 4.7.8. Others
      • 4.7.8.1. Others market, 2021 - 2033 (USD Million)

Chapter 5. Facility Type Business Analysis

  • 5.1. U.S. Cath Labs Market: Facility Type Movement Analysis
  • 5.2. U.S. Cath Labs Market: Facility Type Segment Dashboard
  • 5.3. Facility type Movement & Market Share Analysis, 2025 & 2033
  • 5.4. U.S. Cath Labs Market Estimates & Forecast, by Facility Type
  • 5.5. Independent Labs
    • 5.5.1. Independent labs market, 2021 - 2033 (USD Million)
  • 5.6. Hospital-Based Labs
    • 5.6.1. Hospital-based labs market, 2021 - 2033 (USD Million)

Chapter 6. Manufacturing Company Landscape

  • 6.1. Company Categorization
  • 6.2. Company Market Position Analysis
  • 6.3. Company Share Analysis
  • 6.4. Strategy Mapping
    • 6.4.1. Partnership/Collaboration/Alliance
    • 6.4.2. New Product Launch
    • 6.4.3. Mergers & Acquisitions
    • 6.4.4. Others
  • 6.5. Company Profiles/Listing
    • 6.5.1. Shockwave Medical
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial performance
      • 6.5.1.3. Product benchmarking
      • 6.5.1.4. Strategic initiatives
    • 6.5.2. Boston Scientific Corporation
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial performance
      • 6.5.2.3. Product benchmarking
      • 6.5.2.4. Strategic initiatives
    • 6.5.3. GE Healthcare
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial performance
      • 6.5.3.3. Product benchmarking
      • 6.5.3.4. Strategic initiatives
    • 6.5.4. Koninklijke Philips N.V.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial performance
      • 6.5.4.3. Product benchmarking
      • 6.5.4.4. Strategic initiatives
    • 6.5.5. Siemens Healthineers
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial performance
      • 6.5.5.3. Product benchmarking
      • 6.5.5.4. Strategic initiatives
    • 6.5.6. Abbott Laboratories
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial performance
      • 6.5.6.3. Product benchmarking
      • 6.5.6.4. Strategic initiatives
    • 6.5.7. Stryker
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial performance
      • 6.5.7.3. Product benchmarking
      • 6.5.7.4. Strategic initiatives
    • 6.5.8. Cordis
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial performance
      • 6.5.8.3. Product benchmarking
      • 6.5.8.4. Strategic initiatives
    • 6.5.9. AngioDynamics
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial performance
      • 6.5.9.3. Product benchmarking
      • 6.5.9.4. Strategic initiatives
    • 6.5.10. Medtronic
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial performance
      • 6.5.10.3. Product benchmarking
      • 6.5.10.4. Strategic initiatives
    • 6.5.11. Shimadzu Corporation
      • 6.5.11.1. Overview
      • 6.5.11.2. Financial performance
      • 6.5.11.3. Product benchmarking
      • 6.5.11.4. Strategic initiatives
    • 6.5.12. Johnson & Johnson
      • 6.5.12.1. Overview
      • 6.5.12.2. Financial performance
      • 6.5.12.3. Product benchmarking
      • 6.5.12.4. Strategic initiatives
    • 6.5.13. B. Braun Melsungen AG
      • 6.5.13.1. Overview
      • 6.5.13.2. Financial performance
      • 6.5.13.3. Product benchmarking
      • 6.5.13.4. Strategic initiatives
    • 6.5.14. Cardinal Health, Inc.
      • 6.5.14.1. Overview
      • 6.5.14.2. Financial performance
      • 6.5.14.3. Product benchmarking
      • 6.5.14.4. Strategic initiatives

Chapter 7. Service Provider Company Landscape

  • 7.1. Company Categorization
  • 7.2. Company Market Position Analysis
  • 7.3. Company Share Analysis
  • 7.4. Strategy Mapping
    • 7.4.1. Partnership/Collaboration/Alliance
    • 7.4.2. New Service Launch
    • 7.4.3. Mergers & Acquisitions
    • 7.4.4. Others
  • 7.5. Company Profiles/Listing
    • 7.5.1. Cleveland Clinic
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Service benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Cedars-Sinai
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Service benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Mayo Clinic
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Service benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. NewYork-Presbyterian Hospital
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Service benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. Northwestern Medicine
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Service benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Stanford Health Care
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Service benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Houston Methodist
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Service benchmarking
      • 7.5.7.4. Strategic initiatives
×

원하시는 정보를 찾아 드릴까요?

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기